title: Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation.
authors.forename: Ana
authors.initials: A
authors.lastname: Moreno
authors.forename: Rafael
authors.initials: R
authors.lastname: Bárcena
authors.forename: Carmen
authors.initials: C
authors.lastname: Quereda
authors.forename: José L
authors.initials: JL
authors.lastname: Casado
authors.forename: María J
authors.initials: MJ
authors.lastname: Pérez-Elías
authors.forename: Jesús
authors.initials: J
authors.lastname: Fortún
authors.forename: Javier
authors.initials: J
authors.lastname: Nuño
authors.forename: Isabel
authors.initials: I
authors.lastname: Arranz
authors.forename: Santiago
authors.initials: S
authors.lastname: Moreno
mesh_terms: D000141:Acidosis, Renal Tubular / Q000209:etiology; D058186:Acute Kidney Injury / Q000209:etiology; D004359:Drug Therapy, Combination; D005919:Glomerular Filtration Rate; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000008:administration & dosage*; D019698:Hepatitis C, Chronic / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011760:Pyrrolidinones / Q000008:administration & dosage*; D000068898:Raltegravir Potassium; D020123:Sirolimus / Q000008:administration & dosage*
chemical_list: D019428:HIV Integrase Inhibitors; D007166:Immunosuppressive Agents; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D020123:Sirolimus